Market Place
Sourcing Support
SpliceBio Doses First Patient in Phase 1/2 ASTRA Study of SB-007
13 Mar 2025 //
PR NEWSWIRE
SpliceBio’s SB-007 Cleared By FDA For Stargardt Disease Phase 1/2 Trial
12 Dec 2024 //
PR NEWSWIRE
SpliceBio sparks eye disease gene therapy collab with Roche unit
17 Oct 2023 //
FIERCE BIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.